Etiology and pathophysiology of stroke as a complex trait.

Stroke (brain attack) is currently the third leading cause of death in Western societies. Recent advances in molecular genetics have finally demonstrated what has long been suggested by the clinical observation, that is, stroke is not only the complication of major pathologic conditions such as atherosclerosis, hypertension, or cardiac diseases, but rather it represents a complex trait itself. Thus, the pathogenesis of stroke is often the result of the combined effects of genes exerting a direct contributory role and of their interactions with several environmental determinants. A genetic dissection of stroke has been attempted in suitable animal models and in humans. With this approach, the genetic defects underlying monogenic disorders associated with stroke were identified. Moreover, important findings have recently highlighted the contribution of genes encoding cardiovascular hormones, such as the atrial natriuretic peptide, for the pathogenesis of multifactorial, polygenic forms of stroke. A more thorough understanding of the fine mechanisms, dependent from mutations within stroke susceptibility genes and underlying the disease pathogenesis, may help to introduce new specific tools to achieve better prevention and treatment of stroke.

[1]  T. Meade,et al.  Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study , 1993, The Lancet.

[2]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.

[3]  A. Folsom,et al.  Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. , 1998, The New England journal of medicine.

[4]  W M O'Fallon,et al.  Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. , 1996, Stroke.

[5]  L Tiret,et al.  Sequence diversity in 36 candidate genes for cardiovascular disorders. , 1999, American journal of human genetics.

[6]  B. Stricker,et al.  Excess stroke among hypertensive men and women attributable to undertreatment of hypertension. , 1999, Stroke.

[7]  D. Ganten,et al.  Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease , 1996, Nature Genetics.

[8]  I. Macdonald,et al.  Health issues related to alcohol consumption , 1999 .

[9]  K. Ulm,et al.  Potassium prevents death from strokes in hypertensive rats without lowering blood pressure. , 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[10]  A. Dominiczak,et al.  Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus , 1997, Nature Genetics.

[11]  R. Salama IMMUNITY AND CYSTIC FIBROSIS. , 1965, Lancet.

[12]  S. Strandgaard,et al.  Hypertension and stroke , 1996, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[13]  A. Dominiczak,et al.  Genes encoding atrial and brain natriuretic peptides as candidates for sensitivity to brain ischemia in stroke-prone hypertensive rats. , 1999, Hypertension.

[14]  S. Sasaki,et al.  Fish consumption and mortality from all causes, ischemic heart disease, and stroke: an ecological study. , 1999, Preventive medicine.

[15]  Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.

[16]  W C Willett,et al.  Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. , 1998, Circulation.

[17]  N. Carter,et al.  Molecular approach to assessing the genetic risk of cerebral infarction: deletion polymorphism in the gene encoding angiotensin 1-converting enzyme. , 1994, Journal of human hypertension.

[18]  J. Marshall Familial incidence of cerebrovascular disease. , 1971, Journal of medical genetics.

[19]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[20]  E. Roccella,et al.  Conference report on stroke mortality in the southeastern United States. , 1998, Hypertension.

[21]  C. Warlow Epidemiology of stroke , 1998, The Lancet.

[22]  N. Bishopric,et al.  Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. , 1996, The Journal of biological chemistry.

[23]  K. Merikangas,et al.  A Study of Twins and Stroke , 1992, Stroke.

[24]  J. Manson,et al.  Prospective study of endogenous tissue plasminogen activator and risk of stroke , 1994, The Lancet.

[25]  R. Platt Heredity in hypertension. , 1963, Lancet.

[26]  David L. Rimoin,et al.  Principles and Practice of Medical Genetics , 1990 .

[27]  N. Bishopric,et al.  Atrial Natriuretic Peptide Induces Apoptosis in Neonatal Rat Cardiac Myocytes* , 1997, The Journal of Biological Chemistry.

[28]  G. Condorelli,et al.  Abnormal Hormonal and Renal Responses to Saline Load in Hypertensive Patients With Parental History of Cardiovascular Accidents , 1991, Circulation.

[29]  Chien-Jen Chen,et al.  Secular Trend of Mortality From Cerebral Infarction and Cerebral Hemorrhage in Taiwan, 1974–1988 , 1993, Stroke.

[30]  M. Criqui,et al.  Alcohol drinking and coronary heart disease , 1995 .

[31]  D. Ganten,et al.  Association and cosegregation of stroke with impaired endothelium-dependent vasorelaxation in stroke prone, spontaneously hypertensive rats. , 1996, The Journal of clinical investigation.

[32]  T. Kurtz,et al.  Molecular Variants in the P450c11AS Gene as Determinants of Aldosterone Synthase Activity in the Dahl Rat Model of Hypertension (*) , 1995, The Journal of Biological Chemistry.

[33]  E. Chalmers,et al.  Factor V Leiden, Prothrombin 20210 G → A and the MTHFR C677T Mutations in Childhood Stroke , 1999, Thrombosis and Haemostasis.

[34]  Z. Li,et al.  Blood pressure, cholesterol, and stroke in eastern Asia , 1998, The Lancet.

[35]  K. Okamoto Establishment of the strokeprone spontaneously hypertensive rat (SHR) , 1972 .

[36]  P. Ridker,et al.  Prospective evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of stroke. , 1999, Circulation.

[37]  N. Shen,et al.  Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis , 1999, Nature Genetics.

[38]  H. Markus,et al.  A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. , 1997, Stroke.

[39]  S. Rahman,et al.  Smoking and stroke: a causative role , 1998, BMJ.

[40]  P. Ridker,et al.  The gene encoding atrial natriuretic peptide and the risk of human stroke. , 1999, Circulation.

[41]  P. Wolf,et al.  American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. , 1997, Stroke.

[42]  M. Kaste,et al.  Genetic Polymorphism of Platelet Glycoprotein IIIa in Patients with Acute Myocardial Infarction and Acute Ischaemic Stroke , 1999, Journal of cardiovascular risk.

[43]  L. Wilhelmsen,et al.  Fibrinogen as a risk factor for stroke and myocardial infarction. , 1984, The New England journal of medicine.

[44]  S. Cassidy,et al.  Principles and Practice of Medical Genetics , 1992 .

[45]  J. Laragh,et al.  Relation of plasma renin to end organ damage and to protection of K+ feeding in stroke-prone hypertensive rats. , 1990, Hypertension.

[46]  G. Boers,et al.  Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. , 1985, The New England journal of medicine.

[47]  J. Manson,et al.  Body weight and longevity. A reassessment. , 1987, JAMA.

[48]  W. Willett,et al.  A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. , 1992, JAMA.

[49]  P. Sandercock,et al.  Are hypertension or cardiac embolism likely causes of lacunar infarction? , 1990, Stroke.

[50]  J. Buring,et al.  Light-to-moderate alcohol consumption and the risk of stroke among U.S. male physicians. , 1999, The New England journal of medicine.

[51]  P. Amouyel,et al.  Unhealthy effects of atmospheric temperature and pressure on the occurrence of myocardial infarction and coronary deaths. A 10-year survey: the Lille-World Health Organization MONICA project (Monitoring trends and determinants in cardiovascular disease). , 1999, Circulation.

[52]  L. Hansson The benefits of lowering elevated blood pressure: a critical review of studies of cardiovascular morbidity and mortality in hypertension. , 1996, Journal of hypertension.

[53]  Great Britain. Foreign Office.,et al.  Forty-Fifth Annual Report of the Registrar-General for Scotland , 1900 .

[54]  T. Ogihara,et al.  Dahl's salt-resistant normotensive rat has mutations in cytochrome P450(11 beta), but the salt-sensitive hypertensive rat does not. , 1993, The Journal of biological chemistry.

[55]  J. Lalouel,et al.  A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension , 1992, Nature.

[56]  K. Kangawa,et al.  Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. , 1993, Biochemical and biophysical research communications.

[57]  A. Slivka Effect of antihypertensive therapy on focal stroke in spontaneously hypertensive rats. , 1991, Stroke.

[58]  G Ladurner,et al.  [Prevention of stroke]. , 1999, Wiener klinische Wochenschrift.

[59]  M. Sheridan Letter: The handicapped family. , 1975 .

[60]  P. Ridker,et al.  Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. , 1995, The New England journal of medicine.

[61]  J. Higaki,et al.  Methylenetetrahydrofolate reductase gene polymorphism: relation to blood pressure and cerebrovascular disease. , 1998, American journal of hypertension.

[62]  B. Kaye Dietary potassium and stroke‐associated mortality: A 12‐year prospective population study , 1988 .

[63]  J. Laragh Position Paper: Hypertension, Vasoconstriction, and the Causation of Cardiovascular Injury: The Renin-Sodium Profile as an Indicator of Risk , 1981 .

[64]  E. Barrett-Connor,et al.  Family history of heart attack as an independent predictor of death due to cardiovascular disease. , 1984, Circulation.

[65]  I. Olafsson,et al.  Mutation in the cystatin C gene causes hereditary brain hemorrhage. , 1989, Progress in clinical and biological research.

[66]  Y. Yamori,et al.  Possible role of nutritional factors in the incidence of cerebral lesions in stroke-prone spontaneously hypertensive rats. , 1984, Hypertension.

[67]  K. Lindpaintner,et al.  Altered structure, regulation, and function of the gene encoding the atrial natriuretic peptide in the stroke-prone spontaneously hypertensive rat. , 1999, Circulation research.

[68]  E. Lander,et al.  Characterization of single-nucleotide polymorphisms in coding regions of human genes , 1999 .

[69]  W. Willett,et al.  A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. , 1988, The New England journal of medicine.

[70]  H. Markus,et al.  Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. , 1995, Stroke.

[71]  T. Dawson,et al.  Nitric oxide synthase in models of focal ischemia. , 1997, Stroke.

[72]  R. Quatrano Genomics , 1998, Plant Cell.

[73]  M. Volpe Atrial natriuretic peptide and the baroreflex control of circulation. , 1992, American journal of hypertension.

[74]  D. Connelly,et al.  Implantable defibrillators for life threatening ventricular arrhythmias , 1998, BMJ.

[75]  G. Condorelli,et al.  Dietary salt excess unmasks blunted aldosterone suppression and sodium retention in the stroke-prone phenotype of the spontaneously hypertensive rat , 1993, Journal of hypertension.

[76]  I. Perry Homocysteine, hypertension and stroke , 1999, Journal of Human Hypertension.

[77]  X. Jeunemaître,et al.  Structural analysis and evaluation of the aldosterone synthase gene in hypertension. , 1998, Hypertension.

[78]  C. Hart,et al.  Risk factors and 20-year stroke mortality in men and women in the Renfrew/Paisley study in Scotland. , 1999, Stroke.

[79]  R S Reneman,et al.  In spontaneously hypertensive rats alterations in aortic wall properties precede development of hypertension. , 2000, American journal of physiology. Heart and circulatory physiology.

[80]  P. Grant,et al.  Methylene tetrahydrofolate reductase C677T genotype and stroke. , 1998, Clinical and laboratory haematology.

[81]  R. Collins,et al.  Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. , 1989, Circulation.

[82]  M. Shichiri,et al.  Natriuretic peptides and nitric oxide induce endothelial apoptosis via a cGMP-dependent mechanism. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[83]  P. Wolf,et al.  Risk factors : Prevention and Rehabilitation of Stroke , 1997 .

[84]  J. Weissenbach,et al.  Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia , 1996, Nature.

[85]  N. Aiyar,et al.  Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[86]  I. Olafsson,et al.  MUTATION IN CYSTATIN C GENE CAUSES HEREDITARY BRAIN HAEMORRHAGE , 1988, The Lancet.

[87]  A. Carter,et al.  Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation. , 1999, Circulation.

[88]  A. Térent Increasing incidence of stroke among Swedish women. , 1988, Stroke.

[89]  T. Kurtz,et al.  Linkage of 11β-hydroxylase mutations with altered steroid biosynthesis and blood pressure in the Dahl rat , 1993, Nature Genetics.

[90]  D. Gardner,et al.  N ATRIURETIC P EPTIDES , 1998 .